These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2394356)

  • 1. [Use of the methods of blood protein fractionation for increasing the activity of natural anti-A and anti-B antibodies].
    Klimova KN; Matveeva MA; Mineeva NV
    Gematol Transfuziol; 1990 May; 35(5):16-8. PubMed ID: 2394356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of E. coli for absorbing natural blood serum isohemagglutinins].
    Danilova TN; Klimova KN; Zlatina KM
    Lab Delo; 1980; (8):458-60. PubMed ID: 6157892
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preparation of universal anti-Rh serum using fruglumin].
    Rakitianskaia AA; Bud'ko TV; Shakutina OK
    Gematol Transfuziol; 1984 Jun; 29(6):61-2. PubMed ID: 6432622
    [No Abstract]   [Full Text] [Related]  

  • 4. [Removal of natural anti-A and anti-B isohemagglutinins from antirhesus sera by fractionation methods].
    Mineeva NV; Klimova KN; Nikitova IS
    Gematol Transfuziol; 1984 Apr; 29(4):54-6. PubMed ID: 6428965
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-A and anti-B: what are they and where do they come from?
    Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S74-9. PubMed ID: 26174901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isohemagglutinins and preformed natural antibodies in xenogeneic organ transplantation.
    Hammer C
    Transplant Proc; 1987 Dec; 19(6):4443-7. PubMed ID: 3501189
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal anti-A and anti-B: development as cost-effective reagents.
    Voak D; Lennox E; Sacks S; Milstein C; Darnborough J
    Med Lab Sci; 1982 Apr; 39(2):109-22. PubMed ID: 6811828
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to immunization with A and B human glycoproteins for the procurement of blood grouping reagents.
    Contreras M; Armitage SE; Hewitt PE
    Vox Sang; 1984; 47(3):224-35. PubMed ID: 6464421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of IgG and IgM anti-A with synthetic oligosaccharides.
    Romano EL; Bhardwaj J; Kelly S; Olson M; Lamontagne LR; Leigh JB; Lauzon GJ
    Transplant Proc; 1987 Dec; 19(6):4479-83. PubMed ID: 3321604
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved removal of anti-A and anti-B antibodies from plasma using blood-group-active haptens.
    Blomberg L; Bratt T; Chester MA; Hansson B
    Vox Sang; 1993; 65(2):126-35. PubMed ID: 8212667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the gel system for ABO grouping and D typing.
    Langston MM; Procter JL; Cipolone KM; Stroncek DF
    Transfusion; 1999 Mar; 39(3):300-5. PubMed ID: 10204594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma immunoadsorption combined with exchange for removal of isohemagglutinin in major ABO-incompatible bone marrow transplantation: a case report.
    Akao Y; Matsuzaki M; Naito K; Naoe T; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1258-62. PubMed ID: 3318267
    [No Abstract]   [Full Text] [Related]  

  • 13. [Possibility of the use of pleural fluid for the production of standard ABO system isohemagglutinizing serum].
    Ablitsov NP; Deorditsa LF
    Probl Gematol Pereliv Krovi; 1975 Nov; 20(11):61-2. PubMed ID: 1226390
    [No Abstract]   [Full Text] [Related]  

  • 14. Xenoreactive natural antibodies and isohemagglutinins: a distinct class of antibodies.
    Lin SS; Parker W; Lundberg-Swanson K; Holtzknecht ZE; Platt JL
    Transplant Proc; 1996 Apr; 28(2):573. PubMed ID: 8623278
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
    Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
    Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation and initial characterization of a monoclonal antibody against blood group M].
    Carceller Rosa A
    Sangre (Barc); 1988 Jun; 33(3):220-3. PubMed ID: 3175818
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs.
    Bradley AJ; Test ST; Murad KL; Mitsuyoshi J; Scott MD
    Transfusion; 2001 Oct; 41(10):1225-33. PubMed ID: 11606820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of blood group B antigen with a specific monoclonal antibody (anti-B, b-183).
    Rouger P; Edelman L; Doinel C; Reviron J; Salmon C; Bach JF
    Immunology; 1983 May; 49(1):77-82. PubMed ID: 6840810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of anti-human B blood group monoclonal antibodies suitable as a blood typing reagent.
    Becker MI; Juica F; Jamett A; Tzichinovsky S; Barros S; Aguayo J; De Ioannes AE
    Hybridoma; 1994 Aug; 13(4):303-10. PubMed ID: 7806251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-A/B-IgM/G immune response to accidental A-O transfusion and to Toxocara canis infestation].
    Buchs JP; Maillard H; Nydegger U
    Schweiz Med Wochenschr; 1991 Mar; 121(10):347-50. PubMed ID: 2028238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.